Global Esomeprazole Market 2020-2026
発行: Orion Market Research Pvt Ltd
世界のエソメプラゾール市場は、2020年から2026年の予測期間中、穏やかな成長率を示すと予想されます。エソメプラゾールは、Nexiumのブランド名で米国FDAからAstraZeneca plcに最初に承認されました。胃食道逆流症（GERD）の高い発生率は、世界的な市場成長の主な要因の1つです。 2017年、米国では、エソメプラゾールだけで約900万回処方されました。ただし、処方数は2011年以降継続的に減少しています。エソメプラゾールの代替薬の存在は、市場成長の主要な抑制要因の1つです。エソメプラゾールの化学異性体であるオメプラゾールは、エソメプラゾールの最も一般的な代替品の1つです。
Global Esomeprazole Market Size, Share & Trends Analysis Report, By Disease (Erosive Esophagitis, Gastroesophageal Reflux Disease, Helicobacter Pylori Infection, Other), By Type (Branded and Generic), By Dosage Type (Capsules & Tablets, Injections, and Other) and Forecast, 2020-2026
The global esomeprazole market is anticipated to show a modest growth rate during the forecast period 2020-2026. Esomeprazole was first approved by the US FDA to AstraZeneca plc under the brand name Nexium. High incidences of gastroesophageal reflux disease (GERD) is one of the major factors for the growth of the market all across the globe. In 2017, esomeprazole was prescribed around 9 million times alone in the US. However, prescription numbers are reducing continuously since 2011. The presence of alternative drugs of esomeprazole is one of the major restraining factors for market growth. Omeprazole, a chemical isomer of esomeprazole is one of the most common alternatives of esomeprazole.
The global esomeprazole market is segmented based on disease, type, and dosage type. By disease, the market is further segmented into erosive esophagitis, gastroesophageal reflux disease, helicobacter pylori infection, and others. By type, the market is bifurcated into branded and generic drugs. Significant growth in the generic drug market will be witnessed during the forecast period all across the globe. By dosage type, the market is segmented into capsules & tablets, injections, and others. Capsules & tablets are expected to have a major market share during the forecast period.
By geography, the global esomeprazole market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to hold a considerable market share. However, significant major market growth will be witnessed in Asia-Pacific due to significant revenue generation of Nexium in Japan and China.
The esomeprazole market is consolidated in nature and a few major market players are operating in the market. Some of the major market players include AbbVie Inc, Sanofi SA, Mylan NV, Novartis AG, Teva Pharmaceutical Industries Ltd., Grunenthal GmbH, Glenmark Pharmaceuticals Inc., and Mylan N.V. The market players are adopting growth strategies including mergers & acquisitions, product approvals, and partnerships & collaborations to gain a competitive edge in the market.
The market study of the global esomeprazole market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to breakdown the market in various segments; derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of our reports.
Secondary Sources Include:
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
The Report Covers: